AGP Executive Report

Medtech & Finance: Healthcare Holding Schweiz AG has closed an CHF 80 million syndicated financing to fund more acquisitions and expand its medtech distribution platform, with Liechtensteinische Landesbank among the lenders. Cardiovascular Drugs (Europe): NewAmsterdam Pharma and Menarini received a positive CHMP opinion for Ubeslo® (obicetrapib) and Evlarco® (obicetrapib plus ezetimibe) for primary hypercholesterolemia, with an EU decision expected in 2H26. Disability Benefits (UK): The UK DWP warns PIP claimants that leaving the country for more than four weeks— even for a holiday—must be reported immediately or payments could be reduced or stopped. Public Health Policy (US): A proposed shift toward very high tariffs on imported generic drugs could raise costs in the US and pressure companies to expand domestic manufacturing. Health & Wellness Context: A reminder that Schengen travel rules can affect planning for Liechtenstein residents heading to Spain, depending on nationality.

Medtech Financing: Healthcare Holding Schweiz AG, a major Swiss medtech distributor with Liechtensteinische Landesbank among its lenders, has closed CHF 80 million in syndicated financing to fund further acquisitions and growth. Cardiovascular Drug Watch: NewAmsterdam Pharma and Menarini received a positive CHMP opinion for Ubeslo® (obicetrapib) and Evlarco® (obicetrapib plus ezetimibe) for primary hypercholesterolemia, with an EU marketing authorization decision expected in 2H26. Disability Benefits Rules: UK DWP guidance warns PIP claimants that holidays abroad longer than four weeks can trigger penalties or payment suspension unless they notify the DWP promptly and share travel details. Citizenship Test: The UK’s Life in the UK Test is required for many foreign applicants seeking British citizenship or settlement, with booking, cost, and exam structure set out by the government. Health & Wellness Context: A new piece on global literacy highlights how low adult reading rates—linked to conflict, poverty, and underfunded schooling—can undermine public health and long-term wellbeing.

NewAmsterdam Pharma/ Menarini Update: The EMA’s CHMP has issued a positive opinion for marketing authorization in Europe for Ubeslo® (obicetrapib) and Evlarco® (obicetrapib plus ezetimibe) for primary hypercholesterolemia, with an European Commission decision expected in 2H26—an important step for patients with HeFH and other dyslipidemias. Disability Benefits & Travel Rules: UK DWP guidance is reminding PIP claimants that leaving the country for more than four weeks (even for holidays) must be reported immediately, or payments could be fined or suspended; claimants also need to report other major changes like hospital stays or shifts in daily-living support. Citizenship Test Requirement: The UK sets out the “Life in the UK Test” for foreign applicants seeking citizenship or settlement—45 minutes, 24 questions, booked online at least three days ahead, with a £50 fee and specific exemptions. Medtech Funding in the Region: Healthcare Holding Schweiz AG has closed CHF 80 million in syndicated financing to expand its medtech distributor platform and support further acquisitions. Health & Society Context: A new piece on public service media argues that even as public trust and funding come under pressure, the mission for local health and community information remains more important than ever. Global Health-Adjacent Read: A report on adult literacy gaps highlights how low literacy—often tied to conflict and underinvestment—undermines public health and long-term wellbeing.

Pharma Update: NewAmsterdam Pharma and Menarini Group received a positive CHMP opinion for marketing authorization in Europe for Ubeslo® (obicetrapib) and Evlarco® (obicetrapib plus ezetimibe) for primary hypercholesterolemia, with an expected European Commission decision in 2H26. Medtech Finance: Healthcare Holding Schweiz AG closed CHF 80 million in syndicated financing to fund further acquisitions and growth as a major independent medtech distributor, with Liechtensteinische Landesbank among the syndicate. Disability Benefits (UK): The UK DWP is reminding PIP claimants that leaving the country for more than four weeks—often even for a holiday—must be reported promptly or payments could be fined or suspended. Citizenship Test (UK): Foreign applicants for British citizenship or settlement must pass the Life in the UK Test (45 minutes, 24 questions), booked online at least three days ahead, costing £50, with some exemptions. Health & Society Readiness: A new literacy-focused piece highlights how adult reading skills vary dramatically worldwide, linking low literacy to conflict, poverty, and underinvestment—an issue tied to long-term public health outcomes. Regional Health Context: The Summer 2026 edition of The European is out now, featuring major interviews and features spanning AI, finance, cybersecurity, climate, travel and lifestyle.

Regulatory Update (Europe): NewAmsterdam Pharma and Menarini got a positive CHMP opinion for Ubeslo® (obicetrapib) and Evlarco® (obicetrapib + ezetimibe), moving Europe toward potential marketing authorization for patients with primary hypercholesterolemia. Health Benefits & Travel Rules (UK): The UK DWP is reminding PIP claimants that trips abroad longer than four weeks must be reported immediately, or payments could be fined or suspended; the guidance also covers other key changes like hospital stays and support needs. Citizenship & Health-Adjacent Compliance (UK): Foreign applicants for British citizenship or settlement must pass the Life in the UK Test (book online, £50 fee, 45 minutes, 24 questions), with some exemptions. Medtech Funding (Switzerland/Liechtenstein region): Healthcare Holding Schweiz AG closed CHF 80 million in syndicated financing to expand its medtech distributor platform and support further acquisitions. Public Health Context (Global): A new global literacy roundup highlights how low adult literacy rates—often tied to conflict and underinvestment—can ripple into public health and social stability.

Regulatory Watch: The EMA’s CHMP has issued a positive opinion for NewAmsterdam Pharma and Menarini’s LDL-lowering drugs—Ubeslo® (obicetrapib) and Evlarco® (obicetrapib plus ezetimibe)—moving them closer to European marketing authorization, with an EC decision expected in 2H26. Healthcare Finance: Healthcare Holding Schweiz AG has closed CHF 80 million in syndicated financing, with Liechtensteinische Landesbank among the lenders, aimed at funding further medtech acquisitions and growth. Disability Benefits (UK): The UK DWP is reminding PIP claimants that leaving the country for more than four weeks—even for a holiday—requires prompt notification or payments could be penalized or suspended. Citizenship & Health-Adjacent Policy (UK): Foreign applicants for UK citizenship or settlement must pass the “Life in the UK Test” (45 minutes, 24 questions) booked online at least three days ahead. Global Health Context: A new look at adult literacy highlights how far the gap still runs between the least literate countries and those nearing universal literacy—an issue tied to long-term health and wellbeing.

Regulatory Watch: The EMA’s CHMP has issued a positive opinion for NewAmsterdam Pharma’s obicetrapib drugs—Ubeslo® (obicetrapib monotherapy) and Evlarco® (obicetrapib plus ezetimibe)—for certain patients with primary hypercholesterolemia, with an EU Commission decision expected in 2H26. Medtech Finance: Healthcare Holding Schweiz AG closed CHF 80 million in syndicated financing, with banks including Liechtensteinische Landesbank in the syndicate, aimed at funding further acquisitions and growth in medical technology distribution. Disability Benefits (UK): The UK DWP is reminding PIP claimants that leaving the country for more than four weeks (even for a holiday) must be reported immediately, or payments could be fined or suspended. Citizenship Requirements (UK): Foreign applicants for British citizenship or settlement must pass the “Life in the UK Test” (45 minutes, 24 questions), booked online at least three days ahead. Health & Mobility Policy Angle: The DWP also flags other “change of circumstances” triggers for PIP, including hospital stays and changes in daily living support needs.

Cardiovascular Drug Update: NewAmsterdam Pharma and Menarini say the EMA’s CHMP has issued a positive opinion for marketing authorization in Europe of Ubeslo® (obicetrapib) and Evlarco® (obicetrapib plus ezetimibe), based on Phase 3 results, with an EU decision expected in 2H26. Disability Benefits Reminder: The UK DWP warns PIP claimants that taking a holiday longer than four weeks can trigger penalties, including payment suspension, unless they notify the department and report other major changes. Citizenship Test Details: The UK outlines the “Life in the UK Test” for foreign applicants, including booking rules, cost, and the 45-minute, 24-question format. Medtech Financing in the Region: Healthcare Holding Schweiz AG has closed CHF 80 million in syndicated financing to fund further medtech acquisitions and growth, with Liechtensteinische Landesbank among the lenders. Health & Mobility Policy Context: A broader debate on public service media funding and public trust is resurfacing, with implications for how health and welfare information reaches communities. Travel & Health Planning: Separate travel updates include visa rules and passport ranking shifts, which can affect how people plan time away and access services. Digital Economy Note: A report on Estonia’s unicorn-per-capita ranking highlights how digital ID and startup ecosystems can attract investment—while also warning that such metrics can mislead policymakers.

Cardiovascular Drug Watch: The EMA’s CHMP has issued a positive opinion for NewAmsterdam Pharma’s obicetrapib (Ubeslo®) and the obicetrapib/ezetimibe fixed-dose combo (Evlarco®), based on Phase 3 results, with an EU decision expected in 2H26. Disability Benefits & Travel Rules: The UK DWP is warning PIP claimants that leaving the country for more than four weeks—even for a holiday—can trigger penalties unless they notify the department promptly and report travel details. Healthcare Finance in the Region: Healthcare Holding Schweiz AG has closed CHF 80 million in syndicated financing to support further medtech acquisitions and expansion. Citizenship Test Requirements: The UK says foreign applicants for citizenship or settlement must pass the “Life in the UK Test,” including booking rules, cost, and the 45-minute format. Global Mobility & Health Context: Russia has published the full 2026 list of countries eligible for its unified e-visa, with specific application timing and stay limits.

Regulatory Watch: NewAmsterdam Pharma and Menarini Group got a positive CHMP opinion for Europe-wide marketing authorization of Ubeslo® (obicetrapib) and Evlarco® (obicetrapib + ezetimibe) for primary hypercholesterolemia, based on Phase 3 BROADWAY, BROOKLYN and TANDEM results, with an expected European Commission decision in 2H26. Travel & Disability Benefits: The UK DWP is warning PIP claimants that leaving the country for more than four weeks—even for a holiday—can trigger penalties or payment suspension unless they notify the DWP promptly and follow the rules on travel dates, duration and reasons. Healthcare Financing: Healthcare Holding Schweiz AG closed CHF 80 million in syndicated financing to boost flexibility for further medtech acquisitions and expansion of shared structures. Citizenship & Health Policy Access: The UK also reiterated that foreign applicants must pass the Life in the UK Test for citizenship/settlement, including booking requirements and test format. Trade & Health Supply Chains: Reports say US generic drug tariffs could return hard in 2028 under a proposed 100% rate, raising concerns for medicine costs and supply reliance. Local Context: Liechtenstein is named among small and medium-sized economies pushing for lower trade barriers at a FIT partnership meeting in New Zealand.

Disability Benefits & Travel Rules: The UK DWP is warning PIP claimants that leaving the country for more than four weeks—even for a holiday—must be reported right away, or payments could be fined or suspended. It also flags other “change of circumstances” like hospital stays or needing more/less help with daily living and mobility. Citizenship Test Update: The UK says foreign applicants for citizenship or settlement must pass the “Life in the UK Test,” booked online at least three days ahead, costing £50, with 45 minutes to answer 24 questions on British traditions and customs. Medtech Funding in the Region: Healthcare Holding Schweiz AG has closed CHF 80 million in syndicated financing, with Liechtensteinische Landesbank among the banking syndicate, to support further medtech acquisitions and growth. Trade & Health-Adjacent Policy Watch: A new push in the US could bring steep tariffs on imported generic drugs starting in 2028, raising concerns about medicine supply costs and reliance on overseas ingredients. Liechtenstein in Trade Talks: New Zealand hosted a FIT Partnership meeting focused on cutting trade barriers; Liechtenstein is listed among the 16 small and medium-sized economies involved.

Medtech Finance: Healthcare Holding Schweiz AG (a major Swiss medtech distributor) has closed a CHF 80 million syndicated financing, with UBS Switzerland leading the deal and Liechtensteinische Landesbank among the lenders—aimed at boosting flexibility for more acquisitions and growth. UK Health & Disability Policy: UK guidance highlights that PIP payments can be affected if claimants travel abroad for more than four weeks; people must contact the PIP enquiry line promptly and share dates, destination, and reasons for travel. Citizenship & Health-Adjacent Compliance: The UK also spells out requirements for the “Life in the UK Test” for foreign applicants, including booking rules, cost (£50), and the 45-minute, 24-question format. Trade & Health Supply Chains: Reports say the US is considering very high tariffs on imported generic drugs starting in 2028, raising concerns about costs and reliance on overseas active ingredients. Liechtenstein in Trade Talks: Liechtenstein is listed among the small-and-medium economies in New Zealand’s FIT partnership meeting, focused on reducing trade barriers and supporting a rules-based system.

Public Health & Care Access: A new warning for disabled Britons on PIP: if you’re claiming PIP and plan to be abroad for more than four weeks, you must contact the PIP enquiry line right away and share travel dates, destination, and reason—eligibility and payments can be affected even for holidays. Medicines & Costs: Trump’s proposed 100% tariffs on generic drugs imported into the US in 2028 (rising to 200% later) could reshape global medicine pricing and supply, as the push for US-based manufacturing targets reliance on foreign generic imports. Health Policy & Media Support: An opinion piece highlights how public service media face funding cuts and skepticism, arguing their mission matters more as misinformation and health-related public information needs grow. Trade & Health-Related Supply Chains: Liechtenstein is named among small trade partners in New Zealand’s FIT talks, while a Vietnam–EFTA deal is set to boost bilateral trade—both signals that cross-border rules can indirectly affect access to goods, including medical products.

Public Media & Trust: A new Insight argues that even as public service media lose support and face scepticism, their local mission matters more than ever—pointing to Liechtenstein’s own experience with Radio Liechtenstein ending after a 2024 referendum. Drug Prices & Trade: Trump’s proposal would hit generic drugs with 100% US import tariffs in 2028 (then 200% after a year), raising fresh pressure on global generic supply chains that already supply most US prescriptions. Disability Benefits While Travelling: UK PIP claimants may risk payment changes if they go abroad for more than four weeks without contacting the DWP and sharing travel dates, destination, and reasons. AI Access in Europe: ChatGPT has returned to WhatsApp across the EEA (including Liechtenstein) after an EU enforcement order, letting users message the verified contact without an OpenAI account. Travel Rules for Health & Safety: Austria warns travellers that bringing food, plants, and souvenirs from outside the EU can trigger confiscation or fines without required plant-health documents. E-Visas & Borders: Russia published the full 2026 list of countries eligible for its unified e-visa, with specific application timing rules.

PIP Travel Rules (UK): If you claim Personal Independence Payment and plan to be abroad for more than four weeks, you must contact the PIP enquiry line right away and share your travel dates, destination, length of stay, and the reason for going—because it can affect eligibility. Short trips under four weeks usually don’t count as a change of circumstances. EU AI Access via WhatsApp (Liechtenstein/EEA): ChatGPT has returned to WhatsApp across the EEA (including Liechtenstein) after an EU competition enforcement order. Users can message a verified WhatsApp contact (+1-800-242-8478) for text, images, voice notes, and image generation without needing an OpenAI account (linking an account can raise limits). Customs & Health Safety (Austria): Austria warns travellers that bringing in food, plants, and some souvenirs from outside the EU can lead to confiscation and fines if plant-health documents are missing—Vienna Airport seized tonnes of fruit, vegetables, cut flowers, and living plants earlier in 2026.

EU Competition & AI Access: The European Commission forced Meta to restore WhatsApp access to ChatGPT across the EEA (including Liechtenstein) after a June order; users can message the verified contact 1-800-CHATGPT (+1-800-242-8478) for text, images, voice notes, and image generation without an OpenAI account. Sports Safeguarding in Universities: A new EU-backed ESSEPA study finds safeguarding in higher-education sport is often fragmented, with unclear reporting routes and gaps in protection for athletes off the field. Medical Training Rights: A UK law prioritising certain medical graduates for training is being challenged in court by students, arguing it unfairly blocks some overseas-campus students from NHS foundation placements, with Liechtenstein included in the priority list. Travel Health & Safety at Borders: Austria warns travellers that bringing fruit, plants, and some souvenirs from outside the EU can lead to confiscation and fines without required plant-health documents. Population & Health Context: A global demographic roundup highlights where men outnumber women most, a reminder that health planning often needs local population realities.